1. Home
  2. NEXR vs DCOY Comparison

NEXR vs DCOY Comparison

Compare NEXR & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexera Technologies Ltd Ordinary Shares

NEXR

Nexera Technologies Ltd Ordinary Shares

SELL

Current Price

$1.12

Market Cap

615.5K

ML Signal

SELL

Logo Decoy Therapeutics Inc. Common Stock

DCOY

Decoy Therapeutics Inc. Common Stock

HOLD

Current Price

$0.84

Market Cap

674.8K

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXR
DCOY
Founded
2021
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
615.5K
674.8K
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
NEXR
DCOY
Price
$1.12
$0.84
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 6.9M
40.8K
Earning Date
08-14-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$20.42
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.53
52 Week High
$5.28
$67.68

Technical Indicators

Market Signals
Indicator
NEXR
DCOY
Relative Strength Index (RSI) 48.86 28.56
Support Level $0.91 $0.53
Resistance Level $1.84 $1.24
Average True Range (ATR) 0.21 0.07
MACD 0.01 0.02
Stochastic Oscillator 42.22 0.00

Price Performance

Historical Comparison
NEXR
DCOY

About NEXR Nexera Technologies Ltd Ordinary Shares

Nexera Technologies Ltd focuses on homeland security technologies, artificial intelligence-driven solutions, and detection systems through its subsidiaries and strategic collaborations. The company collaborates with technology partners to distribute and promote new systems such as 3D imaging and electromagnetic threat detection tools, autonomous security technologies, and multi-layered security ecosystems for critical infrastructure and high-traffic venues.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Share on Social Networks: